The global facial skin ablative treatment market is projected to be worth USD 8,394.3 million by 2030, growing at a CAGR of 7.8%, according to P&S Intelligence. This growth can be ascribed to the growing count of aesthetic measures being conducted throughout the globe, the thriving populace of aging individuals, improvements in technology, growing per-capita income, and rising awareness regarding progressive aesthetic treatments, through meetings and conferences.
On the basis of application, the acne and other scars category had the highest revenue share in the facial skin ablative treatment market in the past few years, and it is projected to remain in the leading position in the future as well. This would mainly be because of the high occurrence of acne in both men and women throughout the world.
The Generation Y category led the industry in recent years, on the basis of demography. This is mainly because of the vast populace of the individuals in this age group, joined by the high occurrence of skin illnesses and rising realization regarding looks among them.
In the past few years, North America held the largest share in the facial skin ablative treatment market, and also the region is projected to be dominant in the future as well.
The Asia-Pacific region is projected to grow at the highest development rate in the facial skin ablative treatment market in the coming few years.
This would mainly be because of the rising healthcare investments and personal per-capita income, growing expenditure by manufacturers, growing aesthetic medicinal tourism industry, and rising populace in the region.
As per the United Nations Department of Economic and Social Affairs (UNDESA), the populace of people aged 65 years and more will touch 225.4 million in India, 356.6 million in China, 52.0 million in Brazil, and 84.8 million in the U.S. by 2050.
Hence, the growing count of aesthetic measures being conducted throughout the globe, the thriving populace of aging individuals, improvements in technology, and growing per-capita income, are the major factors contributing to the growth of the facial skin ablative treatment market.